Compare Agilent Technologies Inc (A) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Canopy Growth Corp — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while Canopy Growth Corp trades at $0.99 (market cap $421.10M). The key difference: Agilent Technologies Inc is far larger — about 100.3× Canopy Growth Corp's market cap, and Agilent Technologies Inc pays a 0.68% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| A | CGC | |
|---|---|---|
Market Cap | $42.22B | $421.10M |
Sector | Health | Health |
52-Week High | $157.20 | $1.92 |
52-Week Low | $110.24 | $0.86 |
Enterprise Value | $43.77B | $378.55M |
Dividend Yield | 0.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
